5/3
05:10 pm
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Medium
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
5/3
10:28 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
5/3
10:28 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
5/2
08:11 am
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $222.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $222.00 price target on the stock.
5/2
06:33 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
5/2
06:33 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
4/10
10:19 am
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
4/10
09:36 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
3/22
02:32 pm
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
3/22
01:48 pm
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
3/20
08:08 am
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $220.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $220.00 price target on the stock.
3/20
06:37 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
3/20
06:37 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
3/15
09:36 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
3/1
11:50 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
3/1
06:24 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
3/1
06:24 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
01:31 pm
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
2/29
01:11 pm
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
12:33 pm
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
2/29
12:33 pm
JAZZ
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
2/29
12:00 pm
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
12:00 pm
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
11:36 am
JAZZ
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
07:38 am
JAZZ
Rating for JAZZ
Medium
Report
Rating for JAZZ